DI CESARE, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 690
NA - Nord America 533
EU - Europa 495
SA - Sud America 48
AF - Africa 22
OC - Oceania 8
Totale 1.796
Nazione #
US - Stati Uniti d'America 505
CN - Cina 231
IT - Italia 188
SG - Singapore 158
DE - Germania 113
BD - Bangladesh 80
RU - Federazione Russa 79
KR - Corea 54
VN - Vietnam 53
HK - Hong Kong 51
FI - Finlandia 48
BR - Brasile 35
JP - Giappone 21
FR - Francia 20
CA - Canada 14
IN - India 12
IE - Irlanda 11
NL - Olanda 8
AU - Australia 7
GB - Regno Unito 6
KE - Kenya 6
MX - Messico 6
SE - Svezia 6
DK - Danimarca 5
TR - Turchia 5
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
JM - Giamaica 3
NG - Nigeria 3
UZ - Uzbekistan 3
VE - Venezuela 3
BJ - Benin 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
KG - Kirghizistan 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.796
Città #
Ashburn 119
Singapore 112
Munich 107
Hefei 76
Seoul 53
Hong Kong 48
Helsinki 39
Santa Clara 39
Rome 33
San Jose 33
The Dalles 29
Milan 27
Florence 25
Buffalo 20
Tokyo 19
Beijing 18
Council Bluffs 18
Chandler 17
Ho Chi Minh City 15
Los Angeles 15
Seattle 14
Fairfield 11
Dublin 10
Hanoi 8
New York 8
Shenzhen 8
Woodbridge 8
Dallas 7
Kent 7
Lauterbourg 7
Bengaluru 6
Dearborn 6
Genoa 6
Turin 6
Wilmington 6
Naples 5
Palermo 5
Paris 5
Toronto 5
Altamura 4
Boardman 4
Houston 4
Jyväskylä 4
Lawrence 4
Nairobi 4
São Paulo 4
Tianjin 4
Valby 4
Abuja 3
Amsterdam 3
Asunción 3
Brooklyn 3
Frankfurt am Main 3
Haiphong 3
Melbourne 3
San Diego 3
Shanghai 3
Tashkent 3
Turku 3
Ann Arbor 2
Atlanta 2
Bakersfield 2
Bern 2
Brescia 2
Brisbane 2
Bình Phước 2
Cambridge 2
Chennai 2
Chicago 2
Clifton 2
Cotonou 2
Hillsboro 2
Jeddah 2
Kingston 2
London 2
Macaé 2
Maracaibo 2
Mumbai 2
Newark 2
Orem 2
Pasadena 2
Phủ Từ Sơn 2
Princeton 2
Stockholm 2
São Leopoldo 2
Taranto 2
Venice 2
'Ain Deheb 1
Abu Dhabi 1
Abū Kabīr 1
Acapulco de Juárez 1
Accra 1
Acerra 1
Aci Catena 1
Addis Ababa 1
Almaty 1
Amman 1
Ancarano 1
Andria 1
Arad 1
Totale 1.138
Nome #
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 321
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 205
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa 162
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 113
Anti-Interleukin-17s for successful management of pustular psoriasis 107
Discoid lupus erythematosus affecting the scalp 107
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 99
Therapy of PsO in Special Subsets of Patients 89
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast 78
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience 77
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study 68
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 52
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 48
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study 35
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 34
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index 33
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 28
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 27
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study 25
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 24
Risankizumab in very elderly patients in real-world practice 23
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 21
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 16
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa 15
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa 8
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review 7
Totale 1.822
Categoria #
all - tutte 4.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 2 0 2 1 0 2 0 4 0 0 3 4
2022/202355 2 13 2 4 7 6 5 1 6 0 3 6
2023/202413 1 0 3 0 0 1 0 5 0 1 0 2
2024/2025391 5 12 8 16 33 58 76 53 60 7 23 40
2025/20261.272 112 130 147 62 95 27 85 81 153 95 79 206
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.822